CX-4945 (Silmitasertib) is an ATP-competitive CK2 protein kinase inhibitor with a Ki and an IC50 of 0.38 and 1 nM for recombinant human CK2α, respectively. CX-4945 has broad-spectrum anti-proliferative activity in multiple cancer cell lines. The anti-proliferative activity of CX-4945 against cancer cells correlated with expression levels of the CK2α catalytic subunit. Attenuation of PI3K/Akt signaling by CX-4945 was evidenced by dephosphorylation of Akt on the CK2-specific S129 site and the canonical S473 and T308 regulatory sites. CX-4945 suppresses Akt signaling and inhibits proliferation of HUVEC Cells. CX-4945 causes cell-cycle arrest and selectively induced apoptosis in certain cancer cells. In models of angiogenesis, CX-4945 inhibited human umbilical vein endothelial cell migration, tube formation, and blocked CK2-dependent hypoxia-induced factor 1 alpha (HIF-1α) transcription in cancer cells. Collectively, CX-4945 inhibits pro-angiogenic CK2 signaling in vitro and in vivo. CX-4945 is an inhibitor of Flt-3/Flk-2 and Pim-1.
See how others have used CX-4945. Click on the entry to view the PubMed entry .
PMID: # 30600261 Pankow, S.|Bamberger, C.|Yates, JR.| et al. 2019. Sci Signal. 12:
PMID: # 30142881 Lertsuwan, J.|Lertsuwan, K.|Sawasdichai, A.|Tasnawijitwong, N.|Lee, KY.|Kitchen, P.|Afford, S.|Gaston, K.|Jayaraman, PS.|Satayavivad, J.| et al. 2018. Cancers (Basel). 10:
PMID: # 28223413 Viscarra, JA. et al. 2017. Sci Signal. 10:
PMID: # 28873435 Lustri, AM. et al. 2017. PLoS ONE. 12: e0183932.
PMID: # 27707883 de Bourayne, M.|Gallais, Y.|El Ali, Z.|Rousseau, P.|Damiens, MH.|Cochet, C.|Filhol, O.|Chollet-Martin, S.|Pallardy, M.|Kerdine-Römer, S.| et al. 2017. J. Leukoc. Biol. 101: 703-715.
PMID: # 27033073 Misticone, S. et al. 2016. Methods in molecular biology (Clifton, N.J.). 1388: 95-110.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.